New research has advanced COVID-19 vaccine work in several ways: using a modified live attenuated mumps virus for delivery, showing that a more stable coronavirus spike protein stimulates a stronger immune response, and suggesting ...
Jul 27, 2022
0
122
In a technical tour de force, a collaborative team of Vanderbilt researchers has characterized the antigen-specific immune response to the Pfizer SARS-CoV-2 RNA vaccine.
Jul 22, 2022
0
58
Those widely available COVID-19 vaccinations keeping the majority of the population free from serious illness will not be enough to stop the spread of the virus and its variants, new University of Virginia collaborative research ...
Jul 19, 2022
0
250
Although omicron subvariants of the SARS-CoV-2 pandemic coronavirus have evolved to evade antibody responses from the primary COVID-19 vaccine series, a new laboratory study suggests current vaccine boosters may elicit sufficient ...
Jul 19, 2022
0
99
A monoclonal antibody treatment taken by patients hospitalized with COVID-19 did not improve recovery time but did reduce deaths, according to a study published July 8 in The Lancet Respiratory Medicine.
Jul 11, 2022
0
139
A team of researchers with the Icahn School of Medicine at Mount Sinai reports that immunoglobulin A (IgA) antibodies bind to specific species of related gut bacteria in mice. They published their results in Science Immunology.
Using a state-of-the-art method, researchers at DZNE and the University of Texas have succeeded for the first time at unraveling the effects of autoimmune antibodies that are directed against the brain in detail at the atomic ...
Jul 8, 2022
0
58
Last year, pathologist Jeffrey SoRelle, M.D., and colleagues developed CoVarScan, a rapid COVID-19 test that detects the signatures of eight hotspots on the SARS-CoV-2 virus. Now, after testing CoVarScan on more than 4,000 ...
Jul 3, 2022
0
175
The omicron subvariants BA.1 and BA.2 of SARS-CoV-2 have dominated the COVID-19 pandemic in early 2022. In many countries, these viruses are now outcompeted by emerging subvariants, with BA.5 being responsible for the current ...
Jul 1, 2022
0
149
The experts agree—the pandemic is not over. Infections are ticking up again, fueled by the new variants our immune systems are ill prepared for.
Jul 1, 2022
0
163
